Sundaram Senthil Vel is Chief Executive Officer of Terns Pharmaceuticals Inc.
Person profile
Roles
Terns Pharmaceuticals
Chief Executive Officer
Address
Waltham, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Terns Pharmaceuticals, Inc.
2 Jun 23
4
Terns Pharmaceuticals, Inc.
3 Feb 23
4
Terns Pharmaceuticals, Inc.
8 Jun 22
4
Terns Pharmaceuticals, Inc.
28 Jan 22
4
Terns Pharmaceuticals, Inc.
30 Sep 21
3
Social Capital Suvretta Holdings Corp. I
24 Sep 21
4
Sio Gene Therapies Inc.
19 Apr 21
3
Terns Pharmaceuticals, Inc.
4 Feb 21
4
Axovant Gene Therapies Ltd.
17 Apr 20
4
Axovant Gene Therapies Ltd.
1 Jul 19
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
31 May 23 | TERN Terns Pharmaceuticals | Common Stock | Buy | Acquire P | No | No | 1.41 | 2,111 | 2.98 k | 9,770 |
1 Feb 23 | TERN Terns Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 8.94 | 900,000 | 8.05 mm | 900,000 |
30 Nov 22 | TERN Terns Pharmaceuticals | Common Stock | Buy | Acquire P | No | No | 1.41 | 3 | 4.23 | 7,659 |